Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

New Survey Shows Pediatricians Strongly Prefer Genexa’s Ingredients Over Leading Children’s Tylenol® Products

pediatrician and Genexa partner. “Genexa reflects what we as doctors want to see more of: clean, simple, and effective formulas for acute symptom relief.” The Brand at the Center of a Clean Medicine Movement: These findings reinforce broader market...

Proving the strength of its drug-delivery platform, the Daewoong Therapeutics Microneedle Patch achieves best-in-class bioavailability

their proprietary semaglutide microneedle patch achieved more than 80%relative bioavailability compared to the injectable formulation in a pilot human pharmacokinetic study. This was based on the healthy volunteer study using semaglutide...

Abcentra LLC Commences Phase 2b 'FORTIFY' Trial with First Patient Dosed, Evaluating Orticumab for Cardiovascular Disease

the Board of Abcentra and Managing Partner of Glenbarr Partners. "We believe orticumab has the potential to become a transformative therapy in cardiovascular disease and are proud to support this innovative approach targeting coronary inflammation,...

Viatris announces the approval of the first generic iron sucrose injection in the U.S

for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Known hypersensitivity to iron sucrose. WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Serious...

To advance gene therapy development and manufacturing, ProBio has launched GMP AAV manufacturing services at its Hopewell facility

clients fully integrated services—including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation and aseptic fill/finish—within a single U.S.-based location. This streamlined approach simplifies coordination,...

Jazz Pharmaceuticals announces the U.S. FDA approval of Modeyso™ (dordaviprone) as the first and only treatment for recurrent H3 K27M-mutant diffuse midline glioma

Chief Scientific Officer, Chimerix, a Jazz Pharmaceuticals Company. "We're proud to deliver precisely the kind of transformative innovation we strive for, and we congratulate our combined Chimerix and Jazz team, and the community who worked...

Roche's first respiratory test, powered by TAGS technology, has received FDA clearance for SARS-CoV-2, Influenza A, Influenza B, and RSV

Disease at Roche Diagnostics. "TAGS technology allows for the detection of more targets on a high-throughput platform, which supports diagnostic stewardship while reaching a broader patient population." This launch further expands Roche's...

The MosaiQ AiPlex® Vasculitis assay is now available for clinical use in the European Union and other countries accepting the CE mark

AliveDx, the global in vitro diagnostics company that aims to transform patient care, announces that the MosaiQ AiPlex® Vasculitis (VAS) assay achieved IVDR-CE Mark. This means that the MosaiQ AiPlex VAS assay is now available for clinical use in...

Get visibly lifted with SkinCeuticals' newest lifting solution, A.G.E. Interruptor Ultra Serum for your face

visible signs of aging linked to collagen loss and glycation. It is engineered with double-patented technology and formulated with a potent 34.6% concentration of Flavo-Proxylane™, Rhamnose, and Gentiana Lutea Root Extract. This serum formula with...

MediPharm Labs launches a new nighttime inhaler, expanding its leading CBN oil portfolio

on the success of the Company’s THC Inhaler introduced earlier this year. The new metered dose inhaler delivers a precise formulation of minor cannabinoid CBN and THC in a consistent, smoke-free format. Designed for nighttime use, the product...

FDA approves Apellis' EMPAVELI® (pegcetacoplan) as the first treatment for patients aged 12 and older with C3G and primary IC-MPGN

primary IC-MPGN, and in C3G patients with post-transplant disease recurrence. “EMPAVELI has the potential to be truly transformational for patients with C3G and primary IC-MPGN, who until now have had very few treatment options. In the largest...

Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis, Bringing Total Funding to $17.5M

development is one of the biggest threats to progress in biotech," said Dave Johnson, co-founder and CEO of Dash Bio and former Chief Data & AI Officer at Moderna. "Our platform was designed the right way from day one: real automation, real...

BD Announces the First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

more than 50 BD-conducted pre-clinical and clinical studies, including a device clinical study demonstrating excellent performance with 100% of study participants stating they would likely use the BD Libertas™ Wearable Injector if prescribedi,ii....

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Gene Therapy Assets of Klotho Available

it is partnering with AAVnerGene Inc. (AAVnerGene), a Rockville, MD-based innovation-driven biotech renowned for its transformative technologies in AAV manufacturing and tissue-targeted delivery. Dr. Joseph Sinkule, the CEO of KLTO stated "we...

Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market

high-value markets with practical, differentiated solutions,” said Jeff Yordon, Co-Founder and CEO of Avenacy. “The vial format of Avenacy’s product supports safe handling, and the unique 5-pack presentation helps providers manage high-cost...

Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) as a Sterile Injectable Solution

team is committed to growing our business and being among the leading animal health pharmaceutical companies. For more information please visit, www.cronuspharmausa.com

Made Scientific and Sentinel BioTherapeutics Announce a Strategic Manufacturing Partnership to Advance the Phase I/II Allogeneic ePP Encapsulated Cell Therapy Program

localized immune-modulating therapies for tumors that are unresponsive to current treatments. Sentinel's lead platform delivers potent cytokines, such as IL-2, via encapsulated allogeneic cell-based protein producers (ePPs) designed for...

Sun Pharma Announces the Launch of LEQSELVI™ (deuruxolitinib) in the United States for Treating Severe Alopecia Areata

compared to 4.3% with placebo), and nasopharyngitis (8.1% as compared to 6.7% with placebo). Please see full Prescribing Information Including BOXED WARNING and Medication Guide and see below for Important Safety Information.1 Sun Pharma is...

TrueMed Partners with Alliance Pharmaceuticals Ltd to Combat Sophisticated Counterfeits Using AI-Powered Authentication

Pharmaceuticals Ltd to go beyond traditional investigations by: Scanning product complaint images using TrueMed's AI platform to detect minute inconsistencies invisible to the human eye Generating immediate, digital evidence reports without the...

Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as the First Treatment for Dry Eye Disease Associated with MGD—A Breakthrough in Ophthalmology

is dievini Hopp BioTech holding GmbH & Co. KG, an active investor in Life and Health Sciences companies. For more information please visit, www.novaliq.com.